Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0097
-0.0002 (-2.47%)
Jul 25, 2025, 3:49 PM EDT
Evofem Biosciences Revenue
Evofem Biosciences had revenue of $845.00K in the quarter ending March 31, 2025, a decrease of -76.55%. This brings the company's revenue in the last twelve months to $16.61M, up 3.70% year-over-year. In the year 2024, Evofem Biosciences had annual revenue of $19.36M with 6.28% growth.
Revenue (ttm)
16.61M
Revenue Growth
+3.70%
P/S Ratio
0.07
Revenue / Employee
518.91K
Employees
32
Market Cap
1.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.36M | 1.15M | 6.28% |
Dec 31, 2023 | 18.22M | 1.38M | 8.20% |
Dec 31, 2022 | 16.84M | 8.59M | 104.23% |
Dec 31, 2021 | 8.24M | 7.80M | 1,748.43% |
Dec 31, 2020 | 446.00K | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Evofem Biosciences News
- 4 weeks ago - Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store - PRNewsWire
- 6 weeks ago - Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire
- 2 months ago - Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1 - PRNewsWire
- 2 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $0.85M - Seeking Alpha
- 2 months ago - Evofem Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 3 months ago - Evofem Biosciences to Present at Emerging Growth Conference - PRNewsWire
- 4 months ago - Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics - PRNewsWire
- 4 months ago - Evofem Reports Fourth Consecutive Year of Net Sales Growth - PRNewsWire